WEBINARS
Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Show More
-
OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib... -
OCTOBER 05, 2023 2:00 PM ET
In this session we will help you gain an understanding of a Class II BSC's role in the rapidly growing cell and gene therapy market. We will cover......
-
OCT 05, 2023 | 9:00 AMC.E. CREDITS
Learning Objectives: 1. Explain how obesity impacts the survival of pediatric patients with specific subtypes of leukemia. 2. Describe how obesity impacts T-cell function in pediatric popula...
On Demand
C.E. CREDITS
In the United States, cancer disproportionately impacts Black and African American individuals. Identifying genetic factors underlying cancer disparities has been an important research focus...
On Demand
C.E. CREDITS
One of the central tenets of biology is that our genetics—our genotype—influences the physical characteristics we manifest—our phenotype. But with more than 25,000 human ge...
OCT 05, 2023 | 1:00 AM
C.E. CREDITS
Organoids continue to gain traction in drug discovery efforts as they offer a more biologically relevant disease model than traditional approaches. But they aren't without challenges. Jo...
OCT 04, 2023 | 10:00 AM
C.E. CREDITS
Current clinical methods used to identify epithelial ovarian cancer are often too late – when the cancer is at an advanced stage, leaving the patient with limited therapeutic options....
OCT 04, 2023 | 7:30 AM
C.E. CREDITS
We started our experience with prostate cancer in 2002 with primitive robotic platforms. Our main goal was to provide an alternative to open and laparoscopic surgery....
